1 Anti Diarrheal Drugs Market Overview 1.1 Product Overview and Scope of Anti Diarrheal Drugs 1.2 Anti Diarrheal Drugs Segment by Type 1.2.1 Global Anti Diarrheal Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Prescription Drugs 1.2.3 OTC Drugs 1.3 Anti Diarrheal Drugs Segment by Application 1.3.1 Anti Diarrheal Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Children 1.3.3 Adults 1.4 Global Anti Diarrheal Drugs Market Size Estimates and Forecasts 1.4.1 Global Anti Diarrheal Drugs Revenue 2016-2027 1.4.2 Global Anti Diarrheal Drugs Sales 2016-2027 1.4.3 Anti Diarrheal Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 Anti Diarrheal Drugs Market Competition by Manufacturers 2.1 Global Anti Diarrheal Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global Anti Diarrheal Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Anti Diarrheal Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Anti Diarrheal Drugs Manufacturing Sites, Area Served, Product Type 2.5 Anti Diarrheal Drugs Market Competitive Situation and Trends 2.5.1 Anti Diarrheal Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Anti Diarrheal Drugs Players Market Share by Revenue 2.5.3 Global Anti Diarrheal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Anti Diarrheal Drugs Retrospective Market Scenario by Region 3.1 Global Anti Diarrheal Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Anti Diarrheal Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Anti Diarrheal Drugs Market Facts & Figures by Country 3.3.1 North America Anti Diarrheal Drugs Sales by Country 3.3.2 North America Anti Diarrheal Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Anti Diarrheal Drugs Market Facts & Figures by Country 3.4.1 Europe Anti Diarrheal Drugs Sales by Country 3.4.2 Europe Anti Diarrheal Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Anti Diarrheal Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Anti Diarrheal Drugs Sales by Region 3.5.2 Asia Pacific Anti Diarrheal Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Anti Diarrheal Drugs Market Facts & Figures by Country 3.6.1 Latin America Anti Diarrheal Drugs Sales by Country 3.6.2 Latin America Anti Diarrheal Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Anti Diarrheal Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Anti Diarrheal Drugs Sales by Country 3.7.2 Middle East and Africa Anti Diarrheal Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Anti Diarrheal Drugs Historic Market Analysis by Type 4.1 Global Anti Diarrheal Drugs Sales Market Share by Type (2016-2021) 4.2 Global Anti Diarrheal Drugs Revenue Market Share by Type (2016-2021) 4.3 Global Anti Diarrheal Drugs Price by Type (2016-2021) 5 Global Anti Diarrheal Drugs Historic Market Analysis by Application 5.1 Global Anti Diarrheal Drugs Sales Market Share by Application (2016-2021) 5.2 Global Anti Diarrheal Drugs Revenue Market Share by Application (2016-2021) 5.3 Global Anti Diarrheal Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Actelion 6.1.1 Actelion Corporation Information 6.1.2 Actelion Description and Business Overview 6.1.3 Actelion Anti Diarrheal Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Actelion Product Portfolio 6.1.5 Actelion Recent Developments/Updates 6.2 Lupin 6.2.1 Lupin Corporation Information 6.2.2 Lupin Description and Business Overview 6.2.3 Lupin Anti Diarrheal Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Lupin Product Portfolio 6.2.5 Lupin Recent Developments/Updates 6.3 GSK 6.3.1 GSK Corporation Information 6.3.2 GSK Description and Business Overview 6.3.3 GSK Anti Diarrheal Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 GSK Product Portfolio 6.3.5 GSK Recent Developments/Updates 6.4 Glenmark Pharmaceuticals 6.4.1 Glenmark Pharmaceuticals Corporation Information 6.4.2 Glenmark Pharmaceuticals Description and Business Overview 6.4.3 Glenmark Pharmaceuticals Anti Diarrheal Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Glenmark Pharmaceuticals Product Portfolio 6.4.5 Glenmark Pharmaceuticals Recent Developments/Updates 6.5 Perrigo 6.5.1 Perrigo Corporation Information 6.5.2 Perrigo Description and Business Overview 6.5.3 Perrigo Anti Diarrheal Drugs Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Perrigo Product Portfolio 6.5.5 Perrigo Recent Developments/Updates 6.6 Pfizer 6.6.1 Pfizer Corporation Information 6.6.2 Pfizer Description and Business Overview 6.6.3 Pfizer Anti Diarrheal Drugs Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Pfizer Product Portfolio 6.6.5 Pfizer Recent Developments/Updates 7 Anti Diarrheal Drugs Manufacturing Cost Analysis 7.1 Anti Diarrheal Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Anti Diarrheal Drugs 7.4 Anti Diarrheal Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Anti Diarrheal Drugs Distributors List 8.3 Anti Diarrheal Drugs Customers 9 Anti Diarrheal Drugs Market Dynamics 9.1 Anti Diarrheal Drugs Industry Trends 9.2 Anti Diarrheal Drugs Growth Drivers 9.3 Anti Diarrheal Drugs Market Challenges 9.4 Anti Diarrheal Drugs Market Restraints 10 Global Market Forecast 10.1 Anti Diarrheal Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Anti Diarrheal Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Anti Diarrheal Drugs by Type (2022-2027) 10.2 Anti Diarrheal Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Anti Diarrheal Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Anti Diarrheal Drugs by Application (2022-2027) 10.3 Anti Diarrheal Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Anti Diarrheal Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Anti Diarrheal Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Anti Diarrheal Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Anti Diarrheal Drugs Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Anti Diarrheal Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Anti Diarrheal Drugs Covered in This Study Table 5. Global Anti Diarrheal Drugs Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Anti Diarrheal Drugs Sales Share by Manufacturers (2016-2021) Table 7. Global Anti Diarrheal Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Anti Diarrheal Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Anti Diarrheal Drugs Average Price (USD/Units) of Key Manufacturers (2016-2021) Table 10. Manufacturers Anti Diarrheal Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Anti Diarrheal Drugs Product Type Table 12. Global Anti Diarrheal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Anti Diarrheal Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti Diarrheal Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Anti Diarrheal Drugs Sales by Region (2016-2021) & (K Units) Table 16. Global Anti Diarrheal Drugs Sales Market Share by Region (2016-2021) Table 17. Global Anti Diarrheal Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Anti Diarrheal Drugs Sales by Country (2016-2021) & (K Units) Table 19. North America Anti Diarrheal Drugs Sales Market Share by Country (2016-2021) Table 20. North America Anti Diarrheal Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Anti Diarrheal Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe Anti Diarrheal Drugs Sales by Country (2016-2021) & (K Units) Table 23. Europe Anti Diarrheal Drugs Sales Market Share by Country (2016-2021) Table 24. Europe Anti Diarrheal Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Anti Diarrheal Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Anti Diarrheal Drugs Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Anti Diarrheal Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Anti Diarrheal Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Anti Diarrheal Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America Anti Diarrheal Drugs Sales by Country (2016-2021) & (K Units) Table 31. Latin America Anti Diarrheal Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America Anti Diarrheal Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Anti Diarrheal Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Anti Diarrheal Drugs Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Anti Diarrheal Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Anti Diarrheal Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Anti Diarrheal Drugs Revenue Market Share by Country (2016-2021) Table 38. Global Anti Diarrheal Drugs Sales (K Units) by Type (2016-2021) Table 39. Global Anti Diarrheal Drugs Sales Market Share by Type (2016-2021) Table 40. Global Anti Diarrheal Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global Anti Diarrheal Drugs Revenue Share by Type (2016-2021) Table 42. Global Anti Diarrheal Drugs Price (USD/Units) by Type (2016-2021) Table 43. Global Anti Diarrheal Drugs Sales (K Units) by Application (2016-2021) Table 44. Global Anti Diarrheal Drugs Sales Market Share by Application (2016-2021) Table 45. Global Anti Diarrheal Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global Anti Diarrheal Drugs Revenue Share by Application (2016-2021) Table 47. Global Anti Diarrheal Drugs Price (USD/Units) by Application (2016-2021) Table 48. Actelion Corporation Information Table 49. Actelion Description and Business Overview Table 50. Actelion Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021) Table 51. Actelion Anti Diarrheal Drugs Product Table 52. Actelion Recent Developments/Updates Table 53. Lupin Corporation Information Table 54. Lupin Description and Business Overview Table 55. Lupin Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021) Table 56. Lupin Anti Diarrheal Drugs Product Table 57. Lupin Recent Developments/Updates Table 58. GSK Corporation Information Table 59. GSK Description and Business Overview Table 60. GSK Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021) Table 61. GSK Anti Diarrheal Drugs Product Table 62. GSK Recent Developments/Updates Table 63. Glenmark Pharmaceuticals Corporation Information Table 64. Glenmark Pharmaceuticals Description and Business Overview Table 65. Glenmark Pharmaceuticals Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021) Table 66. Glenmark Pharmaceuticals Anti Diarrheal Drugs Product Table 67. Glenmark Pharmaceuticals Recent Developments/Updates Table 68. Perrigo Corporation Information Table 69. Perrigo Description and Business Overview Table 70. Perrigo Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021) Table 71. Perrigo Anti Diarrheal Drugs Product Table 72. Perrigo Recent Developments/Updates Table 73. Pfizer Corporation Information Table 74. Pfizer Description and Business Overview Table 75. Pfizer Anti Diarrheal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021) Table 76. Pfizer Anti Diarrheal Drugs Product Table 77. Pfizer Recent Developments/Updates Table 78. Production Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. Anti Diarrheal Drugs Distributors List Table 81. Anti Diarrheal Drugs Customers List Table 82. Anti Diarrheal Drugs Market Trends Table 83. Anti Diarrheal Drugs Growth Drivers Table 84. Anti Diarrheal Drugs Market Restraints Table 85. Global Anti Diarrheal Drugs Sales Forecast by Type (2022-2027) & (K Units) Table 86. Global Anti Diarrheal Drugs Sales Market Share Forecast by Type (2022-2027) Table 87. Global Anti Diarrheal Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 88. Global Anti Diarrheal Drugs Revenue Market Share Forecast by Type (2022-2027) Table 89. Global Anti Diarrheal Drugs Sales Forecast by Application (2022-2027) & (K Units) Table 90. Global Anti Diarrheal Drugs Sales Market Share Forecast by Application (2022-2027) Table 91. Global Anti Diarrheal Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 92. Global Anti Diarrheal Drugs Revenue Market Share Forecast by Application (2022-2027) Table 93. Global Anti Diarrheal Drugs Sales Forecast by Region (2022-2027) & (K Units) Table 94. Global Anti Diarrheal Drugs Sales Market Share Forecast by Region (2022-2027) Table 95. Global Anti Diarrheal Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 96. Global Anti Diarrheal Drugs Revenue Market Share Forecast by Region (2022-2027) Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Anti Diarrheal Drugs Figure 2. Global Anti Diarrheal Drugs Market Share by Type in 2020 & 2027 Figure 3. Prescription Drugs Product Picture Figure 4. OTC Drugs Product Picture Figure 5. Global Anti Diarrheal Drugs Market Share by Application in 2020 & 2027 Figure 6. Children Figure 7. Adults Figure 8. Global Anti Diarrheal Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Anti Diarrheal Drugs Market Size 2016-2027 (US$ Million) Figure 10. Global Anti Diarrheal Drugs Sales 2016-2027 (K Units) Figure 11. Global Anti Diarrheal Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 12. Anti Diarrheal Drugs Sales Share by Manufacturers in 2020 Figure 13. Global Anti Diarrheal Drugs Revenue Share by Manufacturers in 2020 Figure 14. The Global 5 and 10 Largest Anti Diarrheal Drugs Players: Market Share by Revenue in 2020 Figure 15. Anti Diarrheal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 16. Global Anti Diarrheal Drugs Sales Market Share by Region (2016-2021) Figure 17. Global Anti Diarrheal Drugs Sales Market Share by Region in 2020 Figure 18. Global Anti Diarrheal Drugs Revenue Market Share by Region (2016-2021) Figure 19. Global Anti Diarrheal Drugs Revenue Market Share by Region in 2020 Figure 20. U.S. Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 21. Canada Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Germany Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. France Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. U.K. Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Italy Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Russia Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. China Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Japan Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. South Korea Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. India Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Australia Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Taiwan Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Indonesia Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Thailand Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Malaysia Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Philippines Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Vietnam Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Mexico Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Argentina Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Turkey Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Saudi Arabia Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. U.A.E Anti Diarrheal Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Sales Market Share of Anti Diarrheal Drugs by Type (2016-2021) Figure 45. Sales Market Share of Anti Diarrheal Drugs by Application (2016-2021) Figure 46. Sales Market Share of Anti Diarrheal Drugs by Application in 2020 Figure 47. Revenue Share of Anti Diarrheal Drugs by Application (2016-2021) Figure 48. Revenue Share of Anti Diarrheal Drugs by Application in 2020 Figure 49. Manufacturing Cost Structure of Anti Diarrheal Drugs Figure 50. Manufacturing Process Analysis of Anti Diarrheal Drugs Figure 51. Anti Diarrheal Drugs Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Actelion Lupin GSK Glenmark Pharmaceuticals Perrigo Pfizer